- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 1.0 mg of DE-122
Total 12530 results
-
Santen Inc.CompletedAge-Related Macular DegenerationUnited States
-
Santen Inc.CompletedAge-Related Macular DegenerationUnited States, Philippines
-
Helios Albert-Schweitzer-Klinik NortheimCompletedColorectal Polyps | Colorectal AdenomasGermany, Poland
-
Luye Pharma Group Ltd.Shang Dong Boan Biotechnology Co., Ltd (Co-sponsor)UnknownHealthy Adults
-
Santen Inc.CompletedAge-Related Macular DegenerationUnited States
-
AO GENERIUMRecruitingMetabolic Diseases | Mucopolysaccharidosis Type IIRussian Federation
-
BioMarin PharmaceuticalTerminatedDuchenne Muscular DystrophyBelgium, Netherlands, France, United Kingdom, Italy
-
HighField Biopharmaceuticals CorporationTigermed Consulting Co., LtdRecruitingSolid Tumor, AdultChina
-
UroGen Pharma Ltd.CompletedNeoplasms | Urologic Diseases | Urinary Bladder Diseases | Bladder CancerIsrael
-
Taisho Pharmaceutical Co., Ltd.Completed
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
aTyr Pharma, Inc.Foundation for Sarcoidosis ResearchCompletedPulmonary SarcoidosisUnited States
-
Vanda PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompletedHypertension | Isolated Systolic Hypertension (ISH)
-
Eli Lilly and CompanyActive, not recruitingNeoplasms, HematologicUnited States, Germany, Australia, Sweden, France, Spain, Italy, Austria, Canada
-
Nektar TherapeuticsCompletedAdvanced or Metastatic Solid Tumors in Patients With Hepatic ImpairmentUnited States
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
H. Lundbeck A/SCompleted
-
Biozeus Biopharmaceutical S.A.Not yet recruitingFemale Sexual Dysfunction | Female Sexual Arousal Disorder
-
Taisho Pharmaceutical Co., Ltd.Completed
-
Taisho Pharmaceutical Co., Ltd.Completed
-
Regado Biosciences, Inc.CompletedHealthy VolunteerUnited States
-
Santen Inc.CompletedOpen-angle Glaucoma, Ocular HypertensionUnited States, Japan
-
Pain TherapeuticsNational Institute on Aging (NIA)CompletedAlzheimer Disease | Alzheimer Disease, Early OnsetUnited States
-
Novo Nordisk A/SCompleted
-
Disphar International B.V.WithdrawnComparative BioavailabilityJordan
-
Cerevel Therapeutics, LLCRecruitingApathy in DementiaUnited States, Canada
-
GenfitSGS Life Sciences, a division of SGS Belgium NVCompleted
-
Hoffmann-La RocheChugai Pharmaceutical Co.TerminatedNeuromyelitis Optica Spectrum Disorder | NMOSDUnited States, Korea, Republic of, Italy, Canada, Japan, Turkey
-
Taisho Pharmaceutical Co., Ltd.Completed
-
IpsenRecruitingPrimary Sclerosing CholangitisUnited States, Spain, Germany, Canada, United Kingdom, Italy, Portugal
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 1Germany
-
Vifor (International) Inc.Labcorp Drug Development IncWithdrawnBeta-ThalassemiaUnited States, Bulgaria, Israel
-
Ionis Pharmaceuticals, Inc.CompletedHuntington's DiseaseCanada, United Kingdom, Germany
-
MediBeaconCompleted
-
Taisho Pharmaceutical Co., Ltd.Completed
-
BayerCompleted
-
Bausch Health Americas, Inc.CompletedRheumatoid ArthritisUnited States
-
Oyster Point Pharma, Inc.CompletedDry Eye DiseaseUnited States
-
Empros Pharma ABCTC Clinical Trial Consultants ABCompletedOverweight or ObesitySweden
-
Novartis PharmaceuticalsCompletedSubacute Cutaneous Lupus ErythematosusGreece, Germany, Italy
-
Janssen R&D IrelandCompleted
-
Pain TherapeuticsNational Institute on Aging (NIA)Completed
-
Kala Pharmaceuticals, Inc.CompletedOcular Infections, Irritations and InflammationsUnited States
-
Manal AbdelmalekCompletedNonalcoholic SteatohepatitisUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
MiMedx Group, Inc.Terminated
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderItaly